Literature DB >> 18070937

Alu elements mediate MYB gene tandem duplication in human T-ALL.

Jennifer O'Neil1, Joelle Tchinda, Alejandro Gutierrez, Lisa Moreau, Richard S Maser, Kwok-Kin Wong, Wei Li, Keith McKenna, X Shirley Liu, Bin Feng, Donna Neuberg, Lewis Silverman, Daniel J DeAngelo, Jeffery L Kutok, Rodney Rothstein, Ronald A DePinho, Lynda Chin, Charles Lee, A Thomas Look.   

Abstract

Recent studies have demonstrated that the MYB oncogene is frequently duplicated in human T cell acute lymphoblastic leukemia (T-ALL). We find that the human MYB locus is flanked by 257-bp Alu repeats and that the duplication is mediated somatically by homologous recombination between the flanking Alu elements on sister chromatids. Nested long-range PCR analysis indicated a low frequency of homologous recombination leading to MYB tandem duplication in the peripheral blood mononuclear cells of approximately 50% of healthy individuals, none of whom had a MYB duplication in the germline. We conclude that Alu-mediated MYB tandem duplication occurs at low frequency during normal thymocyte development and is clonally selected during the molecular pathogenesis of human T-ALL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070937      PMCID: PMC2150982          DOI: 10.1084/jem.20071637

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


T cell acute lymphoblastic leukemia (T-ALL) is a thymocyte malignancy that accounts for 10–15% of childhood and 25% of adult ALL cases. Molecular studies of recurrent chromosomal translocations in T-ALL have indicated a central role for the aberrant expression of transcription factors in the pathobiology of this disease. Dysregulated expression of TAL1, MYC, HOX11, and LMO2, for example, can lead to abnormal proliferation and differentiation arrest of T-lymphoid progenitors (1). More recently, activating mutations of the NOTCH1 gene were identified in >50% of human T-ALL cases (2). NOTCH1 encodes a transmembrane receptor with important functions in T cell development; activation of the receptor leads to proteolytic cleavage and release of the NOTCH intracellular domain, which transits to the nucleus and functions as a component of a transcriptional complex that regulates the expression of MYC and other key target genes (3–5). The MYB transcription factor is the cellular counterpart of the v-Myb oncogene of the acutely transforming avian myeloblastosis virus, which causes a rapidly fatal monoblastic leukemia in chickens (6, 7). Myb is essential for hematopoietic, as well as T cell, development (8, 9), and when overexpressed in thymocytes, v-Myb causes T-ALL (10). Accordingly, retroviral insertion and transcriptional activation of the Myb locus represents one of the most frequent accelerating events in mouse models of T-ALL (11) (http://rtcgd.abcc.ncifcrf.gov/). In human cancers, MYB is known to be amplified in 2 colon cancer cell lines, 4 glioblastoma cell lines, and 29% of BRCA1-mutated primary breast cancer samples (12–14). MYB duplication and translocation was very recently demonstrated in human T-ALL (15, 16). We show that the most important mechanism underlying MYB copy number alteration in T-ALL occurs somatically by homologous recombination between Alu elements, providing a means by which an evolving T-ALL clone develops an increased dosage of MYB during leukemic transformation.

RESULTS AND DISCUSSION

The MYB gene is tandemly duplicated in human T-ALL

While conducting high-resolution microarray-based comparative genomic hybridization (array CGH) analysis of full-complexity DNA derived from 17 established T-ALL cell lines, as well as bone marrow samples from 8 cases of newly diagnosed T-ALL, we observed a highly localized increase in copy number within the 6q23 region, which encompasses the MYB gene and part of the nearby downstream AHI1 gene in 6 cell lines and 2 clinical samples (Fig. 1, A–C; and Figs. S1 and S2, available at http://www.jem.org/cgi/content/full/jem.20071637/DC1).
Figure 1.

The MYB gene is tandemly duplicated in human T-ALL cell lines and patient samples. (A) Ideogram of chromosome 6 showing location of the MYB gene on q23. (B) Array CGH performed on DNAs from 17 T-ALL cell lines with Human Genome CGH 44K Microarrays (Agilent). A localized region on 6q23 surrounding the MYB locus is shown to have increased copy number in six of the cell lines. A 2.3-Mb region of chromosome 6 is shown. The top is centromeric, and the bottom is telomeric. Part of the AHI1 gene directly downstream of MYB is also amplified. NA indicates a probe in an intergenic region. Red indicates increased copy, blue indicates decreased copy, and the intensity of the color reflects the level of increase or decrease. (C) DNAs from leukemic cells in the diagnostic bone marrow of eight T-ALL patients were similarly analyzed by array CGH using Human Genome CGH 244K Microarrays, with an increased MYB copy number identified in two cases. A 500-kb region of chromosome 6 is shown. (D) Fiber-FISH on a T-ALL (TALL1) cell line with a diploid MYB copy number. The fosmid encompassing most of the MYB gene is labeled in green; a fosmid immediately 3′ of the MYB coding sequence is labeled in red. (E) Fiber-FISH on the Supt13 cell line showing a duplication of both fosmids spanning the entire MYB locus oriented in tandem on the same DNA fiber.

The MYB gene is tandemly duplicated in human T-ALL cell lines and patient samples. (A) Ideogram of chromosome 6 showing location of the MYB gene on q23. (B) Array CGH performed on DNAs from 17 T-ALL cell lines with Human Genome CGH 44K Microarrays (Agilent). A localized region on 6q23 surrounding the MYB locus is shown to have increased copy number in six of the cell lines. A 2.3-Mb region of chromosome 6 is shown. The top is centromeric, and the bottom is telomeric. Part of the AHI1 gene directly downstream of MYB is also amplified. NA indicates a probe in an intergenic region. Red indicates increased copy, blue indicates decreased copy, and the intensity of the color reflects the level of increase or decrease. (C) DNAs from leukemic cells in the diagnostic bone marrow of eight T-ALL patients were similarly analyzed by array CGH using Human Genome CGH 244K Microarrays, with an increased MYB copy number identified in two cases. A 500-kb region of chromosome 6 is shown. (D) Fiber-FISH on a T-ALL (TALL1) cell line with a diploid MYB copy number. The fosmid encompassing most of the MYB gene is labeled in green; a fosmid immediately 3′ of the MYB coding sequence is labeled in red. (E) Fiber-FISH on the Supt13 cell line showing a duplication of both fosmids spanning the entire MYB locus oriented in tandem on the same DNA fiber. To determine the mechanisms of increased MYB copy number in T-ALL, we used fluorescent in situ hybridization (FISH) with a commercially available probe for MYB. 2 of the 17 T-ALL cell lines examined showed increased copies of MYB relative to the copy number of the chromosome 6 centromere (Molt4 and Molt13; Table I and Fig. S3, available at http://www.jem.org/cgi/content/full/jem.20071637/DC1), representing translocations of chromosome 6q regions to other chromosomes. These cell lines did not show the localized increases in MYB copy number found with array CGH (Fig. 1 B, samples 7 and 8). In fact, none of the cell lines with a discrete increase in MYB copy number had abnormalities affecting this locus by interphase FISH (Fig. S3). Thus, we postulated that the localized increase of MYB copy number observed by array CGH must affect a region adjacent to one of the normal MYB alleles, resulting in a merged signal by FISH on interphase nuclei and on metaphase chromosome spreads. We therefore used fiber-FISH to hybridize 5′ and 3′ MYB fosmid probes onto stretched DNA fibers from interphase cells of seven different T-ALL cell lines. This strategy demonstrated that MYB is tandemly duplicated on one allele in all five human T-ALL cell lines analyzed with array CGH findings of localized increases in MYB copy number (Fig. 1, D and E; and Table I). Thus, the increased MYB copy number in T-ALL that we and others (15, 16) have observed using array CGH is caused by tandem duplication.
Table I.

Summary of results for 17 T-ALL cell lines

Numbera Cell lineMYB status byarray CGHMYB status byMLPALong-rangePCRBreakpointsubtypeb c Interphase FISHFiber-FISHc
1ALL-SILIncreased copyIncreased copyNegative-largerregion amplifiedNANo increase relativeto centromereTandem duplication
2BE13Increased copyIncreased copyPositive1,2,3No increase relativeto centromereTandem duplication
3CEMIncreased copyIncreased copyPositive6No increase relativeto centromereTandem duplication
4RPMI8402Increased copyIncreased copyPositive3,4,5No increase relativeto centromereND
5Supt13Increased copyIncreased copyPositive2,3No increase relativeto centromereTandem duplication
6DU528Increased copyIncreased copyPositive2,3,4,5No increase relativeto centromereND
7Molt4Increased copyIncreased copyNegativeNAIncreased MYB relative tocentromereND
8Molt13Increased copyIncreased copyNegativeNAIncreased MYB relative tocentromereTandem duplication
9TALL1InconclusiveDeletionPositive4 MYB TranslocationNormal
10PF382No increaseNo increaseNegativeNANDND
11Supt7No increaseNo increasePositiveNDNDND
12Molt16No increaseIncreased copyNegativeNANo increase relativeto centromereND
13DND41No increaseInconclusivePositive1,2,3,4,5No increase relativeto centromereND
14Loucy6q deletionDeletionNegativeNADeletionND
15JurkatNo increaseNo increaseNegativeNANo increase relativeto centromereNormal
16Koptk1No increaseNo increasePositive3,4,5No increase relativeto centromereND
17Supt11No increaseNo increaseNegativeNANo increase relativeto centromereND

Numbers correspond to labels in Fig. S1 and Fig. S4 B.

Based on subtypes shown in Fig. 1 D.

ND, not done; NA, not applicable.

Summary of results for 17 T-ALL cell lines Numbers correspond to labels in Fig. S1 and Fig. S4 B. Based on subtypes shown in Fig. 1 D. ND, not done; NA, not applicable.

Tandem duplication of MYB is mediated by Alu elements flanking the MYB gene

To clone the breakpoints between the duplicated copies of MYB in T-ALL and define the mechanism underlying MYB tandem duplication, we performed long-range PCR. From the duplicated genomic region on chromosome 6, as defined by others (15, 16), and from our own array CGH data on T-ALL cell lines and patient samples (Tables I and II and Fig. 1), we designed a forward primer 54 kb 3′ of the end of the MYB coding sequence and a reverse primer at the 5′ end of the MYB gene (primers 1 and 6; Fig. 2 A). This strategy generated an amplified band of ∼10 kb from T-ALL cell lines (Fig. 2 A). Two more rounds of nested PCR with forward primers progressively 3′ of the MYB gene and reverse primers further 5′ of the MYB gene yielded a 1-kb product that was sequenced (primers 3, 4, 5, 7, and 8; Fig. 2 A). Comparison of the sequence of this product with the normal human genome sequence identified a junction between the duplicated copies of MYB. Analysis of 15 T-ALL samples and cell lines showed that this junction always occurred within a 257-bp region of sequence homology that occurs both 3.5 kb 5′ and 73.5 kb 3′ of MYB. Analysis of this sequence using RepeatMasker (http://www.repeatmasker.org) revealed that it constitutes an Alu element. Alu repeats are short, repetitive DNA sequences of <500 bp that are estimated to account for 10% of the human genome (17). The Alu repeats on either side of the MYB gene are 76% identical, implicating homologous recombination as the underlying mechanism of the tandem duplication (Fig. 2, B and C) (18). Sequence differences between the upstream and downstream Alu elements enabled us to group the junctions of T-ALL cell lines into five classes (Fig. 2 D) (1–5). In each class, the downstream Alu element had merged directly with the upstream Alu region of the duplicated gene in a manner that is most consistent with a synthesis-dependent strand annealing (SDSA) event. In brief, the sequences from the downstream Alu element from one sister chromatid invade the upstream Alu element on the other sister, accompanied by DNA synthesis that proceeds past the downstream homologous sequence. The event is completed by strand annealing of the two ends that now contain identical sequence information (Fig. 3). We demonstrate that Alu elements on either side of the MYB gene mediate its somatic tandem duplication in a significant subset of T-ALL cell lines and patients. Previous reports have identified a larger region of duplication in some samples, which encompasses more than the MYB locus (15, 16). We have also seen that the duplicated region can be larger, and, in these cases, we cannot detect the duplication using our long-range PCR method (e.g., cell line 1 in Fig. 1 B). In these cases, the duplication either occurs by a different mechanism or is mediated by another region of homology.
Table II.

Summary of results for 25 T-ALL patient samples

Numbera MYB status by array CGHb MYB status by MLPALong-Range PCR for tandemduplicationBreakpoint subtypec
1No increaseDeletionPositive1, 2, 3, 4
2Increased copyIncreased copyNegativeNA
3InconclusiveNo increasePositiveND
4No increaseNo increaseNegativeNA
5No increaseNo increasePositiveND
6Increased copyIncreased copy (not inremission)NegativeNA
7No increaseNo increaseNegativeNA
8No increaseNo increasePositiveND
9NDNo increaseNegativeNA
10NDNo increasePositive1, 2, 3, 4
11NDNo increaseNegativeNA
12NDNo increasePositive5
13NDNo increasePositive1, 2, 3, 4, 5
14NDIncreased copy (not inremission)Positive1, 2, 3, 4
15NDNo increaseNegativeNA
16NDNo increaseNegativeNA
17NDNo increasePositive1,2,3
18NDNDNegativeNA
19NDNDPositiveND
20NDNDNegativeNA
21NDNo increaseNegativeNA
22NDNDPositive1, 2, 3, 4, 5
23NDNo increaseNegativeNA
24NDIncreased copyNegativeNA
25NDIncreased copyNegativeNA

Samples 1–8 correspond to samples 1–8 in Fig. S4 C.

ND, not done; NA, not applicable.

Based on subtypes shown in Fig. 1 D.

Figure 2.

(A) Detection of the MYB tandem duplication by long-range PCR. Primers were designed based on the fosmids used in the fiber-FISH experiments (Fig. S3). Primers 1, 6, and 7 were used in long-range PCR to detect the MYB duplication. Primer 2 is a control primer for long-range PCR. Primers 3, 4, 5, and 8 are nested primers used to generate a smaller product that was sequenced. Arrows inside boxes indicate Alu elements and their orientation. Insets show PCR results on representative cell lines. (left) Primers 1 and 6 were used in reaction 1; primers 1 and 7 were used in reaction 2; and primers 1 and 2 were used in reaction 3. (right) After three rounds of nested PCR, a band of 1 kb (reaction 3) was obtained in the CEM cell line, but not in normal thymocyte DNA. Primers 3 and 8 were used in reaction 1; primers 4 and 8 in reaction 2; and primers 5 and 8 in reaction 3. (B) Sequence in upper case is 116 kb downstream of MYB in the AHI1 locus. (C) Sequence in lower case is 3.5 kb upstream of MYB. (D) Sequences 1–5 represent the 5 different junctions between the 2 copies of MYB detected in T-ALL cell lines and primary samples. One additional breakpoint (sequence 6) was identified in normal lymphoblastoid cell line DNA. Underlined sequences represent the proposed crossover region. Fig. S3 is available at http://www.jem.org/cgi/content/full/jem.20071637/DC1.

Figure 3.

Proposed mechanism of (A) A DNA double-strand break occurs in (or near) the Alu element downstream of MYB. (B) The broken DNA strand invades the sister chromatid and pairs with the Alu element upstream of MYB. (C) DNA repair synthesis continues through the MYB gene, and the newly synthesized strand anneals to the broken chromatid by strand annealing. (D) The result is duplication of the sequence between the Alu elements. The sequence of the Alu element between the two copies of MYB (gray box) is a hybrid of the two repeats on either side of MYB, depending on where the strand anneals.

(A) Detection of the MYB tandem duplication by long-range PCR. Primers were designed based on the fosmids used in the fiber-FISH experiments (Fig. S3). Primers 1, 6, and 7 were used in long-range PCR to detect the MYB duplication. Primer 2 is a control primer for long-range PCR. Primers 3, 4, 5, and 8 are nested primers used to generate a smaller product that was sequenced. Arrows inside boxes indicate Alu elements and their orientation. Insets show PCR results on representative cell lines. (left) Primers 1 and 6 were used in reaction 1; primers 1 and 7 were used in reaction 2; and primers 1 and 2 were used in reaction 3. (right) After three rounds of nested PCR, a band of 1 kb (reaction 3) was obtained in the CEM cell line, but not in normal thymocyte DNA. Primers 3 and 8 were used in reaction 1; primers 4 and 8 in reaction 2; and primers 5 and 8 in reaction 3. (B) Sequence in upper case is 116 kb downstream of MYB in the AHI1 locus. (C) Sequence in lower case is 3.5 kb upstream of MYB. (D) Sequences 1–5 represent the 5 different junctions between the 2 copies of MYB detected in T-ALL cell lines and primary samples. One additional breakpoint (sequence 6) was identified in normal lymphoblastoid cell line DNA. Underlined sequences represent the proposed crossover region. Fig. S3 is available at http://www.jem.org/cgi/content/full/jem.20071637/DC1. Proposed mechanism of (A) A DNA double-strand break occurs in (or near) the Alu element downstream of MYB. (B) The broken DNA strand invades the sister chromatid and pairs with the Alu element upstream of MYB. (C) DNA repair synthesis continues through the MYB gene, and the newly synthesized strand anneals to the broken chromatid by strand annealing. (D) The result is duplication of the sequence between the Alu elements. The sequence of the Alu element between the two copies of MYB (gray box) is a hybrid of the two repeats on either side of MYB, depending on where the strand anneals. As shown in Table I, we detected MYB tandem duplication by long-range PCR, but not by multiplex ligation-dependent probe amplification (MLPA) or array CGH in 4 T-ALL cell lines: TALL1, Supt7, DND41, and Koptk1. We also detected MYB tandem duplication by long-range PCR in 11 of 25 (44%) primary T-ALL samples (Table II), which is a higher frequency than that found by MLPA in these samples. Thus, nested long-range PCR detects the tandem duplication in a minority of cells, whereas MLPA and array CGH are quantitative assays that detect MYB tandem duplication only when it occurs in a majority of the cells. Collectively, our results indicate that MYB tandem duplication occurs relatively often in T-ALL patients, but is clonally selected in only approximately one fifth of the cases during evolution of the disease, presumably because some malignant clones have increased MYB copies that have translocated to other chromosomes (as in Molt4 and Molt13; Table I and Fig. S3, available at http://www.jem.org/cgi/content/full/jem.20071637/DC1) or already express sufficient MYB protein levels by virtue of their differentiation state to optimally synergize with other oncogenic events, such as mutation of the NOTCH1 gene (Fig. S4). This conclusion is supported by MLPA analysis showing the absence of MYB tandem duplication in remission samples from two patients whose malignant clones were positive for MYB duplication at diagnosis (Table II). Summary of results for 25 T-ALL patient samples Samples 1–8 correspond to samples 1–8 in Fig. S4 C. ND, not done; NA, not applicable. Based on subtypes shown in Fig. 1 D.

MYB tandem duplication in normal lymphocytes and peripheral blood cells

To determine whether MYB duplication occurs in normal lymphocytes, we performed long-range PCR on 96 DNA samples extracted from lymphoblastoid cell lines from the HapMap panel of individuals. We detected a band representing MYB tandem duplication in 45 of 96 samples (46.9%), and sequencing of all the products revealed that the breakpoints in normal samples were of the 5 types previously identified in T-ALL cell lines (Fig. 2 D), with the identification of one additional breakpoint (no. 6). Further analysis with MLPA did not detect an increase in MYB copy number in any of the 36 HapMap lymphoblastoid cell lines that were analyzed, implying that the duplication occurs infrequently, if at all, as a germline copy number variation, but rather is a somatic event affecting a small fraction of normal lymphocytes. To determine whether RAG expression is necessary for Alu-mediated MYB duplication, we have analyzed the AML cell lines HL60 and Meg01. We have detected the MYB gene duplication in these two lines, and sequencing of the PCR products revealed that the duplication was Alu-mediated, as in the T-ALL cell lines and samples. Therefore, RAG expression is not required for Alu-mediated MYB gene duplication. We also analyzed 10 peripheral blood and 37 buccal swab samples from healthy individuals for the MYB tandem duplication by long-range PCR and MLPA. We detected the duplication in 2 of 10 blood samples and none of 37 buccal samples by long-range PCR. However, none of the blood or buccal samples was positive for MYB tandem duplication by MLPA. These results demonstrate that MYB tandem duplication occurs spontaneously in normal blood cells and is not an artifact of generating lymphoblastoid cell lines from normal cells. They also indicate that circulating blood mononuclear cells are more prone than epithelial cells to undergo MYB tandem duplication through Alu-mediated homologous recombination (Fisher's exact test, P = 0.042). Blood cells may be more likely to undergo this recombination event because they are more prone to double-strand breaks that initiate the Alu-mediated recombination. Recent studies in mice have demonstrated that distinct levels of MYB are required at different stages of hematopoietic development for differentiation and proliferation (19, 20). Therefore, it is not surprising that a relatively modest increase in MYB expression, produced as a result of tandem duplication or translocation of a single copy, would be clonally selected in some T-ALLs during their molecular pathogenesis. Intriguingly, in several of our primary T-ALL samples with evidence by nested long-range PCR of rare cells with MYB tandem duplication, this subset of cells did not have a growth advantage, and the MYB copy number of the majority of cells was normal by CGH and MLPA. Thus, if a particular T-ALL clone already expresses sufficiently high levels of MYB for transformation because of its differentiation state, then the increased levels provided by MYB duplication may not provide an advantage for clonal selection. We and others (15, 16) have observed that MYB duplication occurs often in T-ALL cases with activating mutations in NOTCH1. Knockout studies in the mouse, as well as MYB small interfering RNA experiments in T-ALL cell lines, demonstrated that MYB plays an important role in T cell differentiation (15, 21–23). Furthermore, γ-secretase inhibitors were shown to synergize with MYB small interfering RNA to inhibit T-ALL cell growth (15). These results are consistent with studies in the zebrafish showing that Notch and Myb act in parallel pathways to specify hematopoietic stem cell fate in the AGM (24) and indicate that NOTCH activation and MYB duplication synergize not only in normal blood cell development, but also in malignant T cell transformation. Our study introduces a new mechanism by which an evolving T-ALL clone can increase the dosage of a critical oncogene during leukemic transformation. Homologous recombination between Alu elements in meiotic germ cells leading to deletions and duplications are responsible for several genetic diseases, including glycogen storage disease type II, Lesch-Nyhan syndrome, and Ehler-Danlos syndrome (25). Alu elements have also been implicated in mediating somatic genetic alterations in cancer, such as MLL translocations and partial tandem duplications in acute myelogenous leukemia (26, 27), BRCA1 gene deletions in breast cancer (28), and TRE rearrangement in Ewing's sarcoma (29). Alu elements have also been found near the LMO2 and LCK chromosomal breakpoints in T-ALL (30, 31), suggesting that they may also play role in these chromosomal translocations. Because Alu elements make up a large percentage of the human genome, it is likely that the copy number of many other oncogenes might be increased, or tumor suppressors deleted, through the recombination mechanism that we describe. The emergence of technologies for global comparative genomic hybridization and single-nucleotide polymorphism analysis in human cancers should enable efficient detection of these pathogenic copy number alterations, especially when the analyses are paired with analysis of normal germline DNA from the same individual.

MATERIALS AND METHODS

Patient materials.

Cryopreserved lymphoblasts or lymphoblast lysates ALL were collected with informed consent and institutional review board approval from patients with newly diagnosed T-ALL who were treated with Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 95-001 or 00-001. Genomic DNA was extracted with the PUREGENE kit according to the manufacturer's protocol (Gentra Systems).

Microarray-based CGH.

Genomic DNA was fragmented and random-prime labeled, as previously described (32). Labeled DNAs were hybridized to microarrays containing 44K (cell lines) or 244K (primary samples) 60-mer oligonucleotides (Agilent Technologies), as previously described (33). Microarray data have been deposited in the GEO database under accession no. GSE7615.

FISH.

FISH was performed with a commercially available probe mix containing a MYB (6q23) probe labeled with spectrum aqua and a centromeric probe for chromosome 6 labeled with spectrum orange (Vysis, Inc.). Slides and probe were co-denatured at 75°C, hybridized overnight at 37°C, washed, counterstained with 4′,6-diamidino-2-phenylindole, and analyzed under a fluorescence microscope (Carl Zeiss, Inc.). For each cell line, a minimum of 100 nuclei and any identifiable metaphases were scored. The orange chromosome 6 signals and the aqua LSI MYB signals were counted simultaneously in each nucleus/metaphase. MYB was considered to be amplified if the cells showed more aqua signals than orange signals.

Fiber-FISH.

Cells were lysed overnight using PUREGENE Cell Lysis Solution (Gentra Systems). The DNA was stretched on poly-l-lysine–coated slides, and the DNA fibers were fixed in 100% ethanol. To generate FISH probes, fosmids G248P89100B2 and G248P89828A1 were labeled with digoxigenin and biotin, respectively, using BioPrime Array CGH Labeling Module (Invitrogen). DNA fibers and labeled FISH probes were co-denatured for 3 min at 95°C and hybridized overnight in a humidified chamber at 37°C. The haptens were detected using anti–digoxigenin-fluorescein/Fab fragments (Roche) and Strepavidin/Alexa Fluor 594 conjugate (Invitrogen). Slides were analyzed under a fluorescence microscope (model BX51AI; Olympus). A normal allele showed green dots followed by red dots. A tandem duplication was seen as a direct repeat of the normal signal pattern.

MLPA.

MLPA probe mix containing all probes was added to 150 ng denatured genomic DNA. A universal primer pair was used to amplify all ligated probes in a multiplex PCR assay. The PCR product was analyzed by sequence-type electrophoresis and samples were compared with two control samples. A difference in relative peak area indicated a copy number change of the DNA sequence targeted by the probe. A probe was considered amplified if the ratio sample/control was >1.3.

Long-range PCR.

Reactions were performed with 500 ng of genomic DNA and the LA PCR kit version 2.1 (Takara Mirus Bio) according to the manufacturer's specifications. Primer sequences are available upon request.

Online supplemental material.

Figs. S1 and S2 show array CGH data on T-ALL cell lines and patient samples analyzed by CGH Analytics (Agilent Technologies). Fig. S3 shows MYB FISH on T-ALL cell lines. Lines with tandemly duplicated MYB do not show increased copies of MYB by this method; however, two T-ALL cell lines with extra copies of MYB dispersed to other chromosomes were identified. Fig. S4 shows that MYB duplication results in increased levels of MYB RNA and protein levels in T-ALL cell lines. The online version of this article is available at http://www.jem.org/cgi/content/full/jem.20071637/DC1.
  33 in total

Review 1.  Alu repeats and human genomic diversity.

Authors:  Mark A Batzer; Prescott L Deininger
Journal:  Nat Rev Genet       Date:  2002-05       Impact factor: 53.242

2.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

3.  Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia.

Authors:  Idoya Lahortiga; Kim De Keersmaecker; Pieter Van Vlierberghe; Carlos Graux; Barbara Cauwelier; Frederic Lambert; Nicole Mentens; H Berna Beverloo; Rob Pieters; Frank Speleman; Maria D Odero; Marijke Bauters; Guy Froyen; Peter Marynen; Peter Vandenberghe; Iwona Wlodarska; Jules P P Meijerink; Jan Cools
Journal:  Nat Genet       Date:  2007-04-15       Impact factor: 38.330

4.  MYB oncogene amplification in hereditary BRCA1 breast cancer.

Authors:  P Kauraniemi; I Hedenfalk; K Persson; D J Duggan; M Tanner; O Johannsson; H Olsson; J M Trent; J Isola; A Borg
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

5.  Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16).

Authors:  Yanming Zhang; Nancy Zeleznik-Le; Neelmini Emmanuel; Nimanthi Jayathilaka; Jianjun Chen; Pamela Strissel; Reiner Strick; Loretta Li; Mary Beth Neilly; Tomohiko Taki; Yasuhide Hayashi; Yasuhiko Kaneko; Brigitte Schlegelberger; Janet D Rowley
Journal:  Genes Chromosomes Cancer       Date:  2004-11       Impact factor: 5.006

6.  High-resolution global profiling of genomic alterations with long oligonucleotide microarray.

Authors:  Cameron Brennan; Yunyu Zhang; Christopher Leo; Bin Feng; Craig Cauwels; Andrew J Aguirre; Minjung Kim; Alexei Protopopov; Lynda Chin
Journal:  Cancer Res       Date:  2004-07-15       Impact factor: 12.701

7.  Critical functions for c-Myb at three checkpoints during thymocyte development.

Authors:  Timothy P Bender; Christopher S Kremer; Manfred Kraus; Thorsten Buch; Klaus Rajewsky
Journal:  Nat Immunol       Date:  2004-06-13       Impact factor: 25.606

8.  Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb.

Authors:  Nikla Emambokus; Alexandros Vegiopoulos; Ben Harman; Eric Jenkinson; Graham Anderson; Jon Frampton
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

9.  Requirement of c-myb in T cell development and in mature T cell function.

Authors:  Yen K Lieu; Atul Kumar; Anthony G Pajerowski; Thomas J Rogers; E Premkumar Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-04       Impact factor: 11.205

10.  Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice.

Authors:  Anders H Lund; Geoffrey Turner; Alla Trubetskoy; Els Verhoeven; Ellen Wientjens; Danielle Hulsman; Robert Russell; Ronald A DePinho; Jack Lenz; Maarten van Lohuizen
Journal:  Nat Genet       Date:  2002-08-19       Impact factor: 38.330

View more
  42 in total

1.  Loss of DNA replication control is a potent inducer of gene amplification.

Authors:  Brian M Green; Kenneth J Finn; Joachim J Li
Journal:  Science       Date:  2010-08-20       Impact factor: 47.728

Review 2.  New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer.

Authors:  Göran Stenman; Mattias K Andersson; Ywonne Andrén
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

3.  WT1 mutations in T-ALL.

Authors:  Valeria Tosello; Marc R Mansour; Kelly Barnes; Maddalena Paganin; Maria Luisa Sulis; Sarah Jenkinson; Christopher G Allen; Rosemary E Gale; David C Linch; Teresa Palomero; Pedro Real; Vundavalli Murty; Xiaopan Yao; Susan M Richards; Anthony Goldstone; Jacob Rowe; Giuseppe Basso; Peter H Wiernik; Elisabeth Paietta; Rob Pieters; Martin Horstmann; Jules P P Meijerink; Adolfo A Ferrando
Journal:  Blood       Date:  2009-06-03       Impact factor: 22.113

4.  The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy.

Authors:  Valeria Tosello; Adolfo A Ferrando
Journal:  Ther Adv Hematol       Date:  2013-06

5.  Stress-induced phosphorylation of Thr486 in c-Myb by p38 mitogen-activated protein kinases attenuates conjugation of SUMO-2/3.

Authors:  Juraj Bies; Marek Sramko; Linda Wolff
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

Review 6.  An alternative approach to medical genetics based on modern evolutionary biology. Part 4: HERVs in cancer.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-11       Impact factor: 5.344

7.  Roles of retrotransposons in benign and malignant hematologic disease.

Authors:  Anna M Schneider; Amy S Duffield; David E Symer; Kathleen H Burns
Journal:  Cellscience       Date:  2009-10-27

8.  Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.

Authors:  Alejandro Gutierrez; Takaomi Sanda; Wenxue Ma; Jianhua Zhang; Ruta Grebliunaite; Suzanne Dahlberg; Donna Neuberg; Alexei Protopopov; Stuart S Winter; Richard S Larson; Michael J Borowitz; Lewis B Silverman; Lynda Chin; Stephen P Hunger; Catriona Jamieson; Stephen E Sallan; A Thomas Look
Journal:  Blood       Date:  2010-02-01       Impact factor: 22.113

Review 9.  The molecular basis of T cell acute lymphoblastic leukemia.

Authors:  Pieter Van Vlierberghe; Adolfo Ferrando
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

10.  miR-150 Regulates Memory CD8 T Cell Differentiation via c-Myb.

Authors:  Zeyu Chen; Erietta Stelekati; Makoto Kurachi; Sixiang Yu; Zhangying Cai; Sasikanth Manne; Omar Khan; Xiaolu Yang; E John Wherry
Journal:  Cell Rep       Date:  2017-09-12       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.